MDWD

MediWound Ltd. (MDWD) ESG Analysis Analysis (2026)

Invetso Score: 7.1/10 — Strong · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 6.4 (Moderate)

MDWD’s R&D intensity supports product innovation with limited direct environmental burden, but peer comparison is constrained because the provided metrics do not disclose emissions or resource-use data.

Low leverage and negative net debt reduce balance-sheet pressure that can otherwise delay environmental compliance spending, yet this advantage is financial rather than an environmental operating edge versus peers.

The available data show no evidence of heavy capital intensity or carbon-intensive operations, which is favorable relative to industrial peers, but the absence of disclosed environmental metrics limits confidence.

Because the dataset lacks energy, waste, and climate disclosures, MDWD appears neither structurally advantaged nor disadvantaged environmentally versus peers on the evidence provided.

Social

Score:

R&D spending above revenue suggests sustained investment in product development, which can support patient or customer outcomes and compares favorably with peers that underinvest in innovation.

Stock-based compensation at 17.2% of revenue indicates meaningful employee alignment, though it can also dilute retention benefits relative to peers with lower equity reliance.

The absence of disclosed workforce, safety, or supply-chain incident data prevents a stronger social assessment, but no material controversy is evident in the provided metrics.

Overall social positioning appears stronger than average because the available indicators point to capability-building and alignment, while peer-relative downside signals are limited.

Governance

Score:

Debt-to-equity of 0.27 and net debt below EBITDA indicate conservative leverage, which reduces creditor pressure and supports governance flexibility versus more levered peers.

Stock-based compensation at 17.2% of revenue is material, but it is not unusually high enough on its own to imply weaker governance relative to peers.

The provided metrics do not show aggressive capital structure risk or balance-sheet stress, which typically correlates with stronger oversight and lower governance fragility.

Because no major controversy, restatement, or control failure is indicated in the supplied data, MDWD’s governance profile appears solid relative to peers.

Overall Score

Score:

MDWD’s ESG positioning is stronger than average versus peers, led by conservative leverage and sustained R&D investment, while limited disclosure prevents a higher score.

Score Driver: Conservative Leverage Combined With Sustained R&D Investment Relative To Peers.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on MediWound Ltd.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →